Cellink develops advanced 3D bioprinters and bioinks for the precise fabrication of human tissues, enabling researchers to create patient-specific models for personalized medicine and drug discovery. Their technology addresses the need for more physiologically relevant models in biomedical research, enhancing the understanding of human biology and accelerating therapeutic development.
Funding
$211.1K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods of creating human tissues for research, personalized medicine, and drug discovery often lack the physiological relevance needed to accurately mimic in vivo conditions. Existing models may not fully capture the complex microarchitectures, cell interactions, and biomechanical properties of native tissues, leading to inaccurate results and hindering therapeutic development.
Solution
Cellink provides a range of 3D bioprinting solutions, including bioprinters and bioinks, that enable researchers to create more physiologically relevant human tissue models. Their bioprinters, such as the BIO X series and BIONOVA X, offer features like multi-material printing, high resolution, and temperature control to replicate complex tissue structures. Paired with carefully sourced biomaterials and bioinks, Cellink's technology facilitates the construction of biomimetic models for personalized medicine, drug discovery, regenerative medicine, and cell-cultured food applications. The company's solutions aim to accelerate therapeutic development by providing more accurate in vitro models that better represent in vivo conditions.
Target Audience
The primary target audience includes researchers in tissue engineering, regenerative medicine, personalized medicine, and drug discovery, as well as those involved in developing cell-cultured food and advancing material science.
Features
- BIO X Series: Extrusion-based bioprinters with interchangeable printheads and advanced software (DNA Studio) for coaxial printing and precise control over printing parameters.
- BIO ONE: Biodispensing bioprinter with exceptional cooling capabilities and precision syringe-based extrusion for temperature-sensitive materials.
- BIONOVA X: High-throughput, high-resolution DLP bioprinter for direct in-well printing with multi-material and multi-stiffness gradient capabilities.
- DNA Studio Software: User-friendly software for model generation, print setup, and evaluation, with features like enhanced coaxial printing control.
- Wide range of bioinks: Ready-to-use, tissue-specific, and photo-crosslinkable bioinks, as well as base materials like alginate, collagen, and GelMA.
- Open Material Platform: Bioprinters designed to be compatible with a wide range of biomaterials, allowing users to develop and use their own materials.
- Temperature Control: Precise temperature control during printing, with printhead cooling and heated printbeds to maintain cell viability and material stability.